Clinical Trials Logo

Cognitive Deficit clinical trials

View clinical trials related to Cognitive Deficit.

Filter by:

NCT ID: NCT03036319 Recruiting - Cognitive Deficit Clinical Trials

Patient-Centered NeuroRehabilitation (PCN)

PCN
Start date: June 2016
Phase: N/A
Study type: Interventional

As individuals grow older, a number of factors can reduce our cognitive (or thinking) abilities such as "normal" aging, neurodegenerative diseases, and cardiovascular disease. This study will evaluate whether cognitive rehabilitation and transcranial electrical stimulation (TES) can improve cognitive abilities. Cognitive rehabilitation refers to methods that are used to improve tasks people have trouble doing in everyday life. Transcranial electrical stimulation uses small amounts of electricity to try to alter brain functioning. These approaches may help improve cognitive abilities like attention, learning, memory, finding words, and problem solving as well as everyday functioning. The goal of this study is to identify how to best use these methods, either alone or in combination.

NCT ID: NCT03034109 Terminated - Stroke Clinical Trials

Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits

TDCS-PSMWD
Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effects of tDCS (Transcranial Direct Current Stimulation) on stroke patients with working memory problems.

NCT ID: NCT03032471 Terminated - Stroke Clinical Trials

Swiss SOS MoCA - DCI Study

Start date: July 20, 2017
Phase:
Study type: Observational

The primary objective of this multicenter observational study is to determine the effect size of the relationship between DCI and neuropsychological impairment 14-28 days and 3 months after aSAH. Secondary objectives are the feasibility to administer and the validity of the MoCA in an intensive care unit setting, as well as the test/retest reliability of the MoCA in patients with acute brain damage in absence of aSAH.

NCT ID: NCT02964221 Completed - Clinical trials for Mild Cognitive Impairment

Cognitive Changes After Major Joint Replacement

Cognigram
Start date: June 15, 2016
Phase: N/A
Study type: Observational

Patients assume that cognitive performance rapidly returns to baseline after anesthesia and surgery. Several studies have shown that one week after major non-cardiac surgery about 27% of patients have postoperative cognitive dysfunction (POCD) and 10% of patients at 3 months. Very few studies have assessed the incidence of POCD beyond 3 months. POCD significantly reduces quality of life. Identifying risk factors for POCD is important because it is associated with prolonged hospital stay, loss of independence, and premature retirement. There is an urgent need to measure and document the level of cognitive change associated with surgery with an easy to use tool, both prior to admission and after discharge. This information can be used to plan appropriate care paths and to identify or test the efficacy of potential new treatments to alter the negative trajectory.

NCT ID: NCT02847403 Active, not recruiting - Dysglycemia Clinical Trials

Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients

DRINN
Start date: February 2016
Phase: Phase 3
Study type: Interventional

The overall objective of the study is to assess the potential effects of the long-acting GLP-1 analogue exenatide in preventing/slowing the progression of cognitive dysfunction and related biomarkers in dysglycemic/prediabetic patients with mild cognitive impairment (MCI).

NCT ID: NCT02763397 Not yet recruiting - Cognitive Deficit Clinical Trials

Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease

Start date: May 2016
Phase: N/A
Study type: Interventional

The existing DBS setting in patients with DBS of the globus pallidus interna (GPi), which aims to treat motor symptoms by a high-frequency stimulation, will be temporarily reprogramed to stimulate the NbM at a low frequency using the distal electrodes positioned in the vicinity of the NBM. This study aims to investigate the neuropsychological effect of low frequency stimulation of the nucleus basalis of Meynert (NBM) in advanced Parkinson's disease (PD) patients, who were previously treated with deep brain stimulation (DBS) of the globus pallidus interna (GPi).

NCT ID: NCT02214342 Completed - Cognitive Deficit Clinical Trials

Virtual Reality Based Balance Training in People With Mild Cognitive Impairment

Start date: July 2014
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate an innovative virtual reality-based balance training intervention for improving clinically relevant motor performances (balance and gait) in people with mild cognitive impairment. The investigators hypothesize that the virtual reality-based balance training intervention will improve balance and gait performances in people with mild cognitive impairment compared to a control group receiving usual care only.